Drug Treatment in Rheumatoid Arthritis |
( Volume 5 Issue 3,March 2018 ) OPEN ACCESS |
Author(s): |
Lambrini Kourkouta, Ekaterina Frantzana, Christos Iliadis, Theologia Ziogou |
Abstract: |
Introduction: Rheumatoid arthritis is the most common inflammatory autoimmune rheumatic disease that without proper treatment can cause permanent lesions and deformities of the joints resulting in long-term functional disability or disability. Purpose: In this review study is provided the pharmaceutical treatment of rheumatoid arthritis in order to promote the quality of life of these patients. Material & Methods: The material of the study was a recent article on the topic found mainly in the Medline database and the Hellenic Academic Libraries Association (HEAL-Link). Results: Early diagnosis of the disease, as well as early onset of treatment, helps significantly in the successful management of the disease. Conventional treatment for rheumatoid arthritis includes non-steroidal anti-inflammatory anti-rheumatic drugs or other disease-modifying drugs such as methotrexate and corticosteroids. The goal of medication is to reduce pain and inflammation, minimize loss of function, and prevent complications and joint damage. Conclusions: The goal of pharmaceutical therapy is the recession of inflammation. Treatment planning is also different for each patient; both because the disease is not as severe in everyone as the needs of each patient are different. |
Paper Statistics: |
Cite this Article: |
Click here to get all Styles of Citation using DOI of the article. |